Recent Updates
Recently added Catalysts
ICLR Positive Sentiment Score: 60/100

ICON plc to Attend Upcoming Investor Conferences DUBLIN--(BUSINESS WIRE)

Key Takeaway: ICON plc, a leading clinical research organization, has announced participation in upcoming investor conferences, with CEO Dr. Steve Cutler presenting at the William Blair Annual Growth Stock Conference and CFO Mr. Brendan Brennan attending the UBS Healthcare Services Conference. The company highlighted its role in advancing clinical research and developing innovations across various healthcare sectors. However, the release includes forward-looking statements that acknowledge potential risks and uncertainties that could impact future results.

Market Sentiment Analysis

POSITIVE FACTORS

  • ICON plc is actively engaging with investors at multiple conferences.
  • The company has a strong industry presence with a large workforce across many countries.
  • The forward-looking statements indicate a proactive approach to growth and future opportunities.

CONCERNS & RISKS

  • Management's statements include significant uncertainties that may affect future performance.
  • Potential risks related to client relationships and contract maintenance were mentioned.

Full Press Release Details

ICON plc to Attend Upcoming Investor Conferences

DUBLIN--(BUSINESS WIRE)--May 31, 2023--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 43rd
Annual Growth Stock Conference on Tuesday, June 6, 2023 at 2:40pm CT and Mr. Brendan Brennan, CFO of ICON plc, will attend the UBS Healthcare Services Conference on Wednesday, June 28, 2023.
Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under "Events".
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and
public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 109 locations in 53 countries as at March
31, 2023. For further information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from time
to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions.
The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update
publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by
ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

Contacts

Vice President Investor Relations

Frequently Asked Questions

When will ICON plc present at the William Blair Conference?

ICON plc will present on June 6, 2023, at 2:40pm CT.

Who will attend the UBS Healthcare Services Conference?

Mr. Brendan Brennan, CFO of ICON plc, will attend the conference.

Where can I find updates on ICON's conference participation?

Updates will be posted in the Investor section of ICON's website.

What types of services does ICON plc provide?

ICON plc offers outsourced services for pharmaceutical and healthcare organizations.

When was ICON plc's employee count reported?

The employee count was reported as of March 31, 2023.

Last updated: May 31, 2023